The Rollercoaster Ride of Hope and Dilution: Galmed's Cancer Breakthrough Sends Stock Soaring—But What About the Small Guys?
Unlocking Hope: How FGFR Inhibitors Are Revolutionizing Cancer Treatment and Fueling Market Growth